Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?Kathleen K. Christians, Ben George, Huamin Wang et al.|The Oncologist|2014Cited by 191
Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancerJordan Kharofa, Bradley A. Erickson, Susan Tsai et al.|Radiotherapy and Oncology|2014Cited by 49
Local control in resectable and borderline resectable pancreatic cancer (PCa) treated with preoperative chemoradiation using IMRT or chemotherapy alone.Jordan Kharofa, Bradley A. Erickson, Tracy Kelly et al.|Journal of Clinical Oncology|2013Cited by 3
Association of decline in serum Ca19-9 after neoadjuvant therapy with improved survival among borderline resectable pancreatic cancer patients.Susan Tsai, Kathleen K. Christians, Bradley A. Erickson et al.|Journal of Clinical Oncology|2013Cited by 3